Prognostic reclassification and survival outcomes in intermediate- and poor-risk nonseminomatous germ cell tumors (NSGCT)

被引：0
|
作者：
Jobanputra, Kunal Naishadh
Prakash, Gagan
Arora, Amandeep
Jadhav, Bhagyashri
Pal, Mahendra
Pawar, Akash
Dey, Sayak
Bakshi, Ganesh
Murthy, Vedang
Maitre, Priyamvada
Menon, Nandini Sharrel
Shah, Minit Jalan
Menon, Santosh
Popat, Palak
Ringe-Katdare, Aparna
Sable, Nilesh
Agrawal, Archi
Noronha, Vanita
Prabhash, Kumar
Joshi, Amit
机构：
[1] Tata Mem Hosp, Mumbai, India
[2] Homi Bhabha Natl Inst, Tata Mem Ctr, Mumbai, India
[3] Tata Mem Hosp, Tata Mem Ctr, Mumbai, India
[4] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5033
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Factors Associated With Choriocarcinoma Syndrome Development in Poor-Risk Patients With Germ Cell Tumors
    Rejlekova, Katarina
    Kalavska, Katarina
    Makovnik, Marek
    Hapakova, Nikola
    Chovanec, Michal
    De Angelis, Valentina
    Obertova, Jana
    Palacka, Patrik
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Mego, Michal
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] POOR-RISK GERM-CELL TUMORS - CURRENT PROGRESS AND FUTURE-DIRECTIONS
    MOTZER, RJ
    BAJORIN, DF
    BOSL, GJ
    SEMINARS IN ONCOLOGY, 1992, 19 (02) : 206 - 214
  • [43] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POOR PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT)
    FLEURY, J
    CURE, H
    LEGROS, M
    GUYOT, F
    CONDAT, P
    CHOLLET, P
    PLAGNE, R
    BONE MARROW TRANSPLANTATION, 1992, 10 : 54 - 54
  • [44] Current medical management of patients with poor-risk metastatic germ-cell tumors
    Albany, Costantine
    CURRENT OPINION IN UROLOGY, 2018, 28 (05) : 474 - 478
  • [45] Prognostic significance of elevated serum tumor markers (STM) after the first cycle of chemotherapy in patients with intermediate and poor risk non seminomatous testicular germ cell tumors (NSGCT)
    Batra, A.
    Nayak, B.
    Singh, P.
    Sahoo, R. K.
    Kunhiparambath, H.
    Kaushal, S.
    Seth, A.
    Varshney, A. N.
    Raj, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S778 - S778
  • [46] Brain metastases (BM) of nonseminomatous germ cell tumors (NSGCT): What population of patients should be screened?
    Tryakin, Alexey
    Fedyanin, Mikhail
    Aleshin, Vladimir
    Mikhina, Zoja
    Zakharova, Tatiana
    Sergeev, Urii
    Garin, Avgust
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Prognostic significance of early predicted time to normalization (TTN) of tumor markers in advanced nonseminomatous germ cell tumors (NSGCT): validation study
    Tryakin, A.
    Tjulandin, S.
    Titov, D.
    Zakharova, T.
    Figurin, K.
    Mitin, A.
    Fainstein, I.
    Garin, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 250 - 250
  • [48] UPDATE OF CYCLIC CHEMOTHERAPY IN 100 PATIENTS (PTS) WITH ADVANCED NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT)
    LOGOTHETIS, C
    SAMUELS, M
    SELIG, D
    DEXEUS, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 172 - 172
  • [49] On the necessity for postchemotherapy surgery for residual abdominal masses in metastatic nonseminomatous germ cell tumors (NSGCT) of testis
    Harland, S. J.
    Welch, R.
    Huddart, R.
    Stenning, S.
    Pollock, P.
    Gabe, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] LYMPHOCELES FOLLOWING RETROPERITONEAL LYMPH-NODE DISSECTION FOR NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT)
    KLEIN, MF
    WETTLAUFER, JN
    PETERS, JS
    JOURNAL OF UROLOGY, 1986, 135 (04): : A252 - A252
12345